Continuous glucose monitors were originally designed to help people with diabetes track and better manage their blood sugar (aka ‘blood glucose’). Nowadays, not everyone you see wearing one ...
For the past year, Jonsson has run Lilly Diabetes and Obesity, which means he oversees everything from insulin shots to the newer, high-demand drugs now known as "weight-loss" shots: Mounjaro ...
Complications caused by type 1 diabetes can be spotted years before they develop thanks to data from continuous glucose monitors, new evidence has suggested. Researchers from the University of ...
Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast.
Continuous glucose monitors are small, wearable devices that track blood sugar levels in real-time. While the devices are commonly prescribed to diabetics to titrate medications (e.g. insulin ...
Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast. Sales of ...
For people with diabetes, blood sugar monitoring is one of the most important ways to maintain a healthy lifestyle. A continuous glucose monitor (CGM) is the most convenient option for replacing ...
Eli Lilly reported mixed results for the fourth quarter, even as demand for its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro soared. The company's quarterly earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results